| Web Site: | www.kaipharma.com |
|---|---|
| Headquarters: | 270 Littlefield Avenue South San Francisco, CA 94080 United States |
| Industry: | Biotechnology |
| Investors: | Aberdare Ventures, Delphi Ventures, Intersouth Partners, InterWest Partners, Investor Growth Capital, Kearny Venture Partners, Lumira Capital |
Link up your social media account to automatically promote the positions at KAI Pharmaceuticals.
Get a job alert every time KAI Pharmaceuticals posts a job.
KAI Pharmaceuticals, located in South San Francisco, is a clinical-stage, biopharmaceutical company whose lead peptide product candidate, KAI-4169, is in development for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Building on promising,
1/26/2012 South San Francisco, CA Save This Job
